At Archimica, we're thrilled to explore the transformative potential of Sucrose Octasulfate Potassium Salt (KSOS) in revolutionizing pharmaceutical applications. From enhancing the stability of high-value treatments to improving liposome-based drug delivery systems, ...
Archimica is excited to be a part of DCAT Week 2025, where we'll be showcasing our latest breakthroughs and innovations in pharmaceutical manufacturing. Let's connect and discuss how we can ...
We are happy to announce that Archimica is now CEP (Certification of Suitability) certified by the EDQM (European Directorate for the Quality of Medicines & HealthCare) for our API product, ...
PI Health Sciences announces the acquisition of Archimica S.p.A from Livia Group April 28, 2023 We are pleased to announce that today PI Health Sciences has acquired Archimica S.p.A (headquarter ...